News
Endpoints platform launches new profile system with improved account management features, including streamlined newsletter ...
Patrik Jonsson becomes International president, Ilya Yuffa leads USA division, Kenneth Custer takes over Cardiometabolic ...
Corvus Pharmaceuticals reported new Phase 1 data in atopic dermatitis that sent its stock price up by as much as 35% ...
Lantheus finally came clean about the fate of its experimental radiopharmaceutical for prostate cancer, ...
The AI-focused biotech insitro has laid off 22% of its workforce, the company said in a Thursday statement. Founded ...
Takeda revealed a handful of pipeline cuts in its fourth-quarter earnings results on Thursday, as the company focuses its ...
Illumina on Thursday said the SEC has closed its investigation into the company's $8 billion purchase of Grail and doesn't ...
Vor Bio, founded by famed cancer biologist Siddhartha Mukherjee, is looking for a way out. Its decision to pursue strategic ...
BMS commits $40B for US expansion, Shionogi buys Torii Pharma for $1.05B, Bavarian Nordic extends BARDA deal, multiple ...
'Find a way, or make one': How two scientists hope to revitalize CRISPR's rare disease crisis
Fyodor Urnov and Kiran Musunuru advocate for streamlined CRISPR treatments for rare genetic diseases, partnering with Danaher ...
Los Angeles-based health system Cedars-Sinai is partnering with venture studio Redesign Health to build health tech startups ...
President Trump met with pharma CEOs at the White House. After praising investments, a 'most favored nation' drug pricing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results